Reevaluating the Risk of Serious Adverse Events of Carbonic Anhydrase Inhibitors
Bleicher, Isaac, Elizabeth Rossin, and Demetrios Vavvas. 2022. “Reevaluating the Risk of Serious Adverse Events of Carbonic Anhydrase Inhibitors”. JAMA Ophthalmol 140 (7): 745-46.